Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Tougher German hospital hygiene quality rules are good news for industry

This article was originally published in Clinica

Executive Summary

The passage of new hospital hygiene regulations by the German upper house earlier this month is likely to increase device sterilisation standards, enhance business for original equipment manufacturers and boost the standing of the diagnostics industry. Better hygiene disease prevention measures have long been advocated by the IVDs lobby group, the VDGH.

You may also be interested in...



German Industry's 'State Of The Nation' Urges Higher Profile For Medtech In 2018

Other than regulatory concerns, 2017 was a relatively problem-free year for Germany's medtech industry. But that is not expected to last far into 2018, according to the industry group BVMed, which this week laid out its priorities for the year ahead. It seems likely that a new government comprising the same coalition partners as in the previous administration will be decided early in the new year, and with it will come new health-care policy aims and budgets for 2017-2021.

The Sustainability Stakes Are Rising: ‘We Cannot Recycle Our Way Out Of This’

The journey to Net Zero, described as ‘the defining issue of our time,’ will get harder in the coming decade. Failure to keep up the pressure will result in more long-term health conditions, increasing deaths and higher costs. The UK NHS is a Net Zero exemplar globally, but without a systemic approach, its compliance efforts could stutter.

UK Life Sciences Cautiously Upbeat For Investment Year Ahead – BioWales 2024

Favorable UK biopharma investment trends have been reported by the BioIndustry Association, but can medtech and healthtech share in the positivity? A roundtable at the BioWales in London 2024 event framed the outlook for non-pharma players.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT097628

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel